CervoMed Inc. cotiza a 2.51 USD y tiene una capitalización bursátil de $38M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the bloodbrain barrier and inhibits the enzyme p38a. Neflamapimod h…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.64 | $-0.86 | $-0.88 |
| Estimado | $-0.58 | $-0.86 | $-0.79 | $-0.70 |
| Sorpresa | — | +25.6% | -8.9% | -25.7% |
| Métrica | CRVO | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -706.2% | -38.6% | -667.6% |
| Net Margin | -673.1% | -33.6% | -639.5% |
| FCF Margin | — | -13.9% | — |
| ROE | -148.0% | -40.4% | -107.6% |
| ROA | -117.9% | -32.0% | -85.9% |
| Current Ratio | 4.91 | 2.84 | +2.07 |
| Debt / Equity | — | 0.28 | — |